Skip to content
MS
Sign in
unreviewed

CETP

0 reactions · 0 pathways

What it does, reaction by reaction

0 reactions

This enzyme appears only in the regulation table, with no catalysed step recorded.

What accelerates and inhibits it

Regulation is pathway-specific, so each context is listed separately

1 entries

Lipoprotein Metabolism (Exogenous and Endogenous Pathways: chylomicrons, VLDL, LDL, HDL)

Accelerated by

HDL and apoB-particle substrate availability

Inhibited by

CETP inhibitors

Hormonal control

Not primarily under acute hormonal control; activity relates to lipoprotein milieu

Recent literature

Refresh

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Efficacy and Safety of Oral Non-Statin Lipid-Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta-Analysis.

    Hodrob T, Saad RJ, Hamdy A, Alheneedy MS, Elsayed AMSA, Ghazy E, Ayesh H. · 2026-11-01

    open access unreviewed
  2. 2
    Associations of plasma HDL subclasses with incident dementia risk in older adults.

    An B, Ali S, Smith K, Roemhild S, Neumann L, Stoll DR, Li L, Lutsey PL, Mielke MM, Yu F, Hoogeveen RC, Zhang … · 2026-10-01

    open access unreviewed
  3. 3
    Distinct Plasma Proteomic Signatures Distinguish MASLD From Non-Steatotic Individuals but Not From MetALD.

    Jakhar N, Seibel T, Mironova M, Meeßen C, Clusmann J, Chen Y, Raju TB, Koop PH, Pearce JE, Costa IG, Stiehl T… · 2026-10-01

    open access unreviewed
  4. 4
    Convex approaches to isolate the shared and distinct genetic components of complex traits.

    Banerjee S, O'Connell S, Colbert SMC, Mullins N, Knowles DA. · 2026-10-01

    open access unreviewed
  5. 5
    COPI Coatomer Regulates Several Steps of HDL Metabolism.

    Panteloglou G, Zanoni P, Law CS, Woods B, Othman A, Yalcinkaya M, Norrelykke SF, Rzepiela AJ, Stoma S, Steble… · 2026-08-13

    unreviewed
  6. 6
    HDL-associated proteins affecting CVD and systemic inflammation.

    Delk SC, Reddy ST. · 2026-08-12

    unreviewed
  7. 7
    Efficacy and Safety of CETP Inhibitors in Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

    Rodríguez Milán R, Jiménez Castellanos MS, Doníz Viveros AD, Yusufzai MO, Espinoza EEC, Estela Fernández CA, … · 2026-10-01

    unreviewed
  8. 8
    Revisiting hypocholesterolemia during prolonged sepsis: From targeted cholesterol repletion to unresolved adrenal and muscle dysfunction.

    De Bruyn L, Van Beek F, Vander Perre S, Derde S, Derese I, Pauwels L, Van den Berghe G, Langouche L. · 2026-06-18

    open access unreviewed
  9. 9
    Structural optimization of cholesteryl ester transfer protein inhibitors: From early scaffolds to advanced clinical candidates.

    Abdollahzadeh M, Ramezani M, Hatamipour M. · 2026-05-08

    unreviewed
  10. 10
    The p53–p21–Cyclin D2 regulatory axis drives metabolic reprogramming and a distinct senescent macrophage senotype during aging and MASLD

    · 2026-09-28

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.